NURS 6630 Midterm Exam / NURS6630 Midterm Exam:
Psychopharmacologic Approaches to Treatment of
Psychopathology Actual Exam Complete Questions &
Rationales | Psychiatric Meds | Pass Guaranteed - A+ Graded
Neurobiology & Mechanisms of Action
Q1: A PMHNP is reviewing the neurobiology of depression with a patient who asks why
their medication takes several weeks to work. The PMHNP explains that while SSRIs
rapidly increase synaptic serotonin, the therapeutic effect is delayed due to which
downstream mechanism?
A. Immediate depletion of dopamine in the mesolimbic pathway
B. Gradual desensitization of somatodendritic 5-HT1A autoreceptors and enhanced
neuroplasticity through BDNF upregulation [CORRECT]
C. Rapid blockade of NMDA receptors leading to immediate glutamate suppression
D. Instant activation of the HPA axis and cortisol normalization
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, we prioritize understanding
the mechanism behind the delay—SSRIs flood the synapse with serotonin right away,
but the 5-HT1A autoreceptors on the raphe neurons sense that excess and initially slow
firing. Over weeks, those autoreceptors desensitize, allowing sustained increased firing,
,and downstream BDNF and neuroplasticity changes correlate with clinical
improvement. Remember that the therapeutic lag isn't about the drug not working
immediately; it's about the brain needing time to adapt its receptor sensitivity and grow
new connections.
Q2: Which neurotransmitter system is primarily responsible for the extrapyramidal side
effects (EPS) seen with first-generation antipsychotics?
A. Serotonergic hyperstimulation in the raphe nuclei
B. Dopamine blockade in the nigrostriatal pathway [CORRECT]
C. GABAergic inhibition in the cerebellar cortex
D. Cholinergic overstimulation in the basal forebrain
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, first-generation antipsychotics
are potent D2 antagonists, and while that helps with psychosis in the mesolimbic
pathway, the nigrostriatal pathway also relies on dopamine for smooth motor control.
Blockade there causes parkinsonism, dystonia, akathisia, and tardive dyskinesia.
Remember that the nigrostriatal pathway is why EPS is so common with high-potency
typicals and why atypical antipsychotics with lower D2 affinity or rapid dissociation
cause fewer motor side effects.
Q3: The locus coeruleus is the primary source of which neurotransmitter in the central
nervous system, and its dysregulation is implicated in anxiety disorders and PTSD?
A. Serotonin
,B. Dopamine
C. Norepinephrine [CORRECT]
D. Acetylcholine
Correct Answer: C
Rationale: The best answer is C. In psychopharmacology, the locus coeruleus is a small
nucleus in the brainstem that provides most of the brain's norepinephrine, and it's
essentially the alarm center—overactive firing correlates with hypervigilance, startle
response, and anxiety symptoms. That aligns with the mechanism because SNRIs and
noradrenergic agents like prazosin target this system in PTSD and anxiety disorders.
Q4: Which receptor is the primary target of benzodiazepines, and what is its
endogenous ligand?
A. Dopamine D2 receptor, with dopamine as the endogenous ligand
B. GABA-A receptor, with GABA as the endogenous ligand [CORRECT]
C. Serotonin 5-HT2A receptor, with serotonin as the endogenous ligand
D. NMDA receptor, with glutamate as the endogenous ligand
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, benzodiazepines bind to a
specific allosteric site on the GABA-A receptor complex, enhancing the effect of
GABA—the brain's main inhibitory neurotransmitter. They don't directly open the chloride
channel; they make GABA more effective at doing so. Remember that this is why
, benzodiazepines are sedating, anxiolytic, and muscle-relaxing, and also why combining
them with other GABAergic substances like alcohol is so dangerous.
Q5: Ketamine's rapid antidepressant effect is primarily attributed to which mechanism?
A. Direct serotonin reuptake inhibition similar to SSRIs
B. NMDA receptor antagonism leading to increased glutamate release, AMPA receptor
activation, and mTOR signaling with synaptogenesis [CORRECT]
C. Monoamine oxidase inhibition preventing neurotransmitter breakdown
D. Direct dopamine D2 receptor blockade reducing psychomotor agitation
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, ketamine is an NMDA receptor
antagonist, but its antidepressant effect paradoxically involves a transient glutamate
surge that activates AMPA receptors and triggers mTOR signaling. That cascade
promotes synaptic protein synthesis and synaptogenesis—literally growing new
connections in hours rather than weeks. Remember that this is fundamentally different
from monoamine-based antidepressants and explains why ketamine can work in
treatment-resistant depression when other agents have failed.
Q6: Which enzyme is responsible for the metabolism of most SSRIs and many other
psychotropic medications, making genetic polymorphisms in this enzyme clinically
significant for dosing and side effect prediction?
A. COMT (catechol-O-methyltransferase)
B. CYP2D6 [CORRECT]
Psychopharmacologic Approaches to Treatment of
Psychopathology Actual Exam Complete Questions &
Rationales | Psychiatric Meds | Pass Guaranteed - A+ Graded
Neurobiology & Mechanisms of Action
Q1: A PMHNP is reviewing the neurobiology of depression with a patient who asks why
their medication takes several weeks to work. The PMHNP explains that while SSRIs
rapidly increase synaptic serotonin, the therapeutic effect is delayed due to which
downstream mechanism?
A. Immediate depletion of dopamine in the mesolimbic pathway
B. Gradual desensitization of somatodendritic 5-HT1A autoreceptors and enhanced
neuroplasticity through BDNF upregulation [CORRECT]
C. Rapid blockade of NMDA receptors leading to immediate glutamate suppression
D. Instant activation of the HPA axis and cortisol normalization
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, we prioritize understanding
the mechanism behind the delay—SSRIs flood the synapse with serotonin right away,
but the 5-HT1A autoreceptors on the raphe neurons sense that excess and initially slow
firing. Over weeks, those autoreceptors desensitize, allowing sustained increased firing,
,and downstream BDNF and neuroplasticity changes correlate with clinical
improvement. Remember that the therapeutic lag isn't about the drug not working
immediately; it's about the brain needing time to adapt its receptor sensitivity and grow
new connections.
Q2: Which neurotransmitter system is primarily responsible for the extrapyramidal side
effects (EPS) seen with first-generation antipsychotics?
A. Serotonergic hyperstimulation in the raphe nuclei
B. Dopamine blockade in the nigrostriatal pathway [CORRECT]
C. GABAergic inhibition in the cerebellar cortex
D. Cholinergic overstimulation in the basal forebrain
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, first-generation antipsychotics
are potent D2 antagonists, and while that helps with psychosis in the mesolimbic
pathway, the nigrostriatal pathway also relies on dopamine for smooth motor control.
Blockade there causes parkinsonism, dystonia, akathisia, and tardive dyskinesia.
Remember that the nigrostriatal pathway is why EPS is so common with high-potency
typicals and why atypical antipsychotics with lower D2 affinity or rapid dissociation
cause fewer motor side effects.
Q3: The locus coeruleus is the primary source of which neurotransmitter in the central
nervous system, and its dysregulation is implicated in anxiety disorders and PTSD?
A. Serotonin
,B. Dopamine
C. Norepinephrine [CORRECT]
D. Acetylcholine
Correct Answer: C
Rationale: The best answer is C. In psychopharmacology, the locus coeruleus is a small
nucleus in the brainstem that provides most of the brain's norepinephrine, and it's
essentially the alarm center—overactive firing correlates with hypervigilance, startle
response, and anxiety symptoms. That aligns with the mechanism because SNRIs and
noradrenergic agents like prazosin target this system in PTSD and anxiety disorders.
Q4: Which receptor is the primary target of benzodiazepines, and what is its
endogenous ligand?
A. Dopamine D2 receptor, with dopamine as the endogenous ligand
B. GABA-A receptor, with GABA as the endogenous ligand [CORRECT]
C. Serotonin 5-HT2A receptor, with serotonin as the endogenous ligand
D. NMDA receptor, with glutamate as the endogenous ligand
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, benzodiazepines bind to a
specific allosteric site on the GABA-A receptor complex, enhancing the effect of
GABA—the brain's main inhibitory neurotransmitter. They don't directly open the chloride
channel; they make GABA more effective at doing so. Remember that this is why
, benzodiazepines are sedating, anxiolytic, and muscle-relaxing, and also why combining
them with other GABAergic substances like alcohol is so dangerous.
Q5: Ketamine's rapid antidepressant effect is primarily attributed to which mechanism?
A. Direct serotonin reuptake inhibition similar to SSRIs
B. NMDA receptor antagonism leading to increased glutamate release, AMPA receptor
activation, and mTOR signaling with synaptogenesis [CORRECT]
C. Monoamine oxidase inhibition preventing neurotransmitter breakdown
D. Direct dopamine D2 receptor blockade reducing psychomotor agitation
Correct Answer: B
Rationale: The best answer is B. In psychopharmacology, ketamine is an NMDA receptor
antagonist, but its antidepressant effect paradoxically involves a transient glutamate
surge that activates AMPA receptors and triggers mTOR signaling. That cascade
promotes synaptic protein synthesis and synaptogenesis—literally growing new
connections in hours rather than weeks. Remember that this is fundamentally different
from monoamine-based antidepressants and explains why ketamine can work in
treatment-resistant depression when other agents have failed.
Q6: Which enzyme is responsible for the metabolism of most SSRIs and many other
psychotropic medications, making genetic polymorphisms in this enzyme clinically
significant for dosing and side effect prediction?
A. COMT (catechol-O-methyltransferase)
B. CYP2D6 [CORRECT]
